Perspective Therapeutics Inc. (CATX)
Statistics
Key valuation multiples, financial performance ratios, profitability metrics, and per share data consolidated into a single structured view. Each metric is benchmarked against both industry and sector averages — providing immediate context on whether the company is trading at a premium or discount relative to its direct peers and the broader market segment.
Valuation & Market Metrics
Market Capitalization
287,662,000
EV to revenue ratio (TTM)
68.73
EV to ebitda
-21.91
Financial Performance
Revenue (TTM)
409,000
Gross profit (TTM)
-95,770,000
EBITDA
-121,186,000
Profitability
Operating margin (TTM)
-36,121.00%
Profit margin
0.00%
Return on assets (TTM)
-22.30%
Return on equity (TTM)
-39.60%
Per Share Metrics
Revenue per share (TTM)
0
EPS
-1.33
Diluted EPS (TTM)
-1.33
Book value
2.84
Dividend per share
Dividend yield
Valuation Multiples
P/E ratio
Trailing P/E
Forward P/E
25.71
PEG ratio
Price to sales ratio (TTM)
703.33
Price to book ratio (TTM)
0.923
Growth
Quarterly earnings growth (YoY)
-72.10%
Quarterly revenue growth (YoY)
0.00%
Analyst Sentiment
Strong buy
2
Buy
12
Hold
1
Sell
0
Strong sell
0
Risk & Volatility
Beta
1.803